Prolinex Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Prolinex General Information

Description

Provider of metabolic profiling to a wide range of diseases. The company engages in identifying a range of metabolic deficiences associated with prevalent diseases such as osteoporosis, rheumatoid arthritis and heart disease.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Other Healthcare Services
Acquirer
Primary Office
  • 2nd Floor, Hanover House 30 Charlotte Street
  • Manchester M1 4EX
  • England, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Prolinex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Jan-2009 Completed Startup
1. Early Stage VC Completed Startup
To view Prolinex’s complete valuation and funding history, request access »

Prolinex Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Total Medical Ventures Venture Capital Minority 000 0000 000000 0
To view Prolinex’s complete investors history, request access »